These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 18207296

  • 1. Risk assessment due to environmental exposures to fibrous particulates associated with taconite ore.
    Wilson R, McConnell EE, Ross M, Axten CW, Nolan RP.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S232-45. PubMed ID: 18207296
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF, Gibbs GW.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [Abstract] [Full Text] [Related]

  • 3. Rapporteur's Report Session 6: risk assessment of asbestos and other fibrous mineral particulates.
    Nolan RP, Langer AM.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S246-8. PubMed ID: 18585424
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of airborne and waterborne particles around a taconite ore processing facility.
    Axten CW, Foster D.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S66-72. PubMed ID: 18221826
    [Abstract] [Full Text] [Related]

  • 5. Mesothelioma and asbestos.
    Gibbs GW, Berry G.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S223-31. PubMed ID: 18022298
    [Abstract] [Full Text] [Related]

  • 6. Rapporteur's Report Session 2: characterization of fibrous minerals.
    Langer AM.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S73-4. PubMed ID: 18585423
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW, Crump KS.
    Crit Rev Toxicol; 2008 Oct; 38 Suppl 1():1-47. PubMed ID: 18671157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mineralogical and microscopic evaluation of coarse taconite tailings from Minnesota taconite operations.
    Zanko LM, Niles HB, Oreskovich JA.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S51-65. PubMed ID: 18166256
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The origins of public concern with taconite and human health: Reserve Mining and the asbestos case.
    Berndt ME, Brice WC.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S31-9. PubMed ID: 18055081
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapporteur's Report Session 1: origin of the problem.
    Ross M.
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S40-2. PubMed ID: 18984323
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.